Dernières nouvelles
Information non disponible
- Blanchet, ManonEmployéHôpital de l'Enfant-Jésus+1 418-649-0252, poste 63530manon.blanchet@crchudequebec.ulaval.ca
1401 18e Rue
Recherche neuromusculaire
P-0140
Québec, QC
Canada G1J 1Z4 - Simard, AlexandraEmployéHôpital de l'Enfant-Jésus+1 418-649-0252, poste 63559Alexandra.Simard@crchudequebec.ulaval.ca
1401, 18e Rue
Recherche neuromusculaire
P-0145
Québec, Québec
Canada G1J 1Z4
Hypogammaglobulinemia and Infection Risk in an Ocrelizumab-treated Multiple Sclerosis Cohort
Article de revueCan J Neurol Sci, 2024.
Virtual Management of Multiple Sclerosis: Providing Access or Just Phoning it in
Article de revueCan J Neurol Sci, 51 (1), 2024.
Clinical course, imaging, and pathological features of 45 adult and pediatric cases of myelin oligodendrocyte glycoprotein antibody-associated disease
Article de revueMult Scler Relat Disord, 76 , 2023.
A pilot study comparing myelin measurements from myelin water imaging and 11C-PIB PET in multiple sclerosis
Article de revueMult Scler Relat Disord, 68 , 2022.
Autoimmune storm following alemtuzumab
Article de revueBMJ Case Rep, 15 (6), 2022.
SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation
Article de revueFront Immunol, 13 , 2022.
Case Report: Acute Necrotizing Encephalopathy Following COVID-19 Vaccine
Article de revueFront Neurol, 13 , 2022.
Acephalgic Intracranial Hypotension: Subdural Haematoma Resolution After Blood Patch
Article de revueCan J Neurol Sci, 49 (1), 2022.
Videoconferencing and Multiple Sclerosis Management: Stopgap or Stay Tuned?
Article de revueCan J Neurol Sci, 49 (3), 2022.
Projets actifs
- Immunoablation avec autogreffe de cellules-souches hématopoïétiques pour la sclérose en plaques sévère - mise en place d'une plate-forme de recherche et protocole de suivi, du 2024-03-31 au 2027-03-31